Evaluating the cost-benefit profile of CPI stem cell therapy requires a comprehensive perspective. Supporters often stress the opportunity for significant therapeutic outcomes, particularly in conditions where conventional therapies have proven ineffective. However, crucially important to assess the substantial financial expenditure associated with